Osteoporosis News and Research

Latest Osteoporosis News and Research

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

Adheris, Inc., an inVentiv Health company, filed suit today against the U.S. Department of Health and Human Services, asking a federal court to enjoin the government from implementing a new regulation that imposes unconstitutional restrictions on the speech of a company whose business is encouraging patients to properly take their medicine.

7 Sep 2013

Osteoporosis drug could provide effective pain relief to patients with osteoarthritis

St George's, University of London research has found that a drug normally given to osteoporosis sufferers could provide effective pain relief to patients with knee and hip osteoarthritis.

6 Sep 2013

New systematic review analyzes patterns of vitamin D status worldwide

A new systematic review published in the British Journal of Nutrition, is one of the first to focus on patterns of vitamin D status worldwide and in key population subgroups, using continuous values for 25(OH)D to improve comparisons.

5 Sep 2013

Southampton researchers investigates influence of mechanical forces on cellular, molecular processes

University of Southampton researchers are at the forefront of research into mechanobiology, an emerging field of science combining biology and engineering, which investigates the influence of mechanical forces on cellular and molecular processes.

5 Sep 2013

Researchers develop first animal model simulating eye complications linked with Graves' disease

Researchers have developed the first animal model simulating the eye complications associated with the thyroid condition Graves' disease, a breakthrough that could pave the way for better treatments, according to a recent study accepted for publication in The Endocrine Society's journal Endocrinology.

3 Sep 2013

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Women undergoing treatment for breast cancer are widely prescribed calcium and vitamin D supplements to prevent and manage osteoporosis, an unwanted side effect of breast cancer therapies.

28 Aug 2013

$Coordinator-based FLS helps identify, manage people at high risk of secondary fractures$

Coordinator-based FLS helps identify, manage people at high risk of secondary fractures

...

27 Aug 2013

Researchers provide support for potential importance of vitamin D in pregnancy

Researchers at the MRC Lifecourse Epidemiology Unit, University of Southampton, have demonstrated that the degree to which a gene related to vitamin D action is switched on or off, when measured at birth, predicts bone density of the child at four years of age.

16 Aug 2013

FDA publishes new regulation defining "gluten-free" for food labeling to protect people with celiac disease

The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.

3 Aug 2013

Reinnervate's Alvetex Scaffold system chosen for 3D osteocytic cell culture experiments in microgravity

Market leading 3D cell culture company Reinnervate Ltd today announced that its Alvetex®Scaffold system has been chosen by a group at Massachusetts General Hospital for the first ever 3D osteocytic cell culture experiments in microgravity.

31 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

FDA grants orphan-drug designation for Ligand’s Captisol-enabled Topiramate Injection

Ligand Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its proprietary Captisol-enabled Topiramate Injection for the treatment of partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate.

26 Jul 2013

HONEI review shows that high glycemic index foods can exacerbate acne

A review carried out by the University of Hull has shed new light on the relationship between acne and diet. Published in Dermatological Nursing, the comprehensive review assesses the latest evidence and findings about the effects of food and nutrition on acne and suggest that high glycemic index foods such as milk could exacerbate the skin condition.

25 Jul 2013

Ligand Pharmaceuticals, Ethicor Pharma sign license agreement for lasofoxifene

Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.

24 Jul 2013

UL researcher receives €1.5 million to develop innovative treatments for bone-loss diseases

UL researcher, Dr David Hoey was announced as one of the recipients of the highly prestigious European Research Council (ERC) starting grants. Dr Hoey has been awarded €1.5 million to pursue cutting-edge fundamental research into developing innovative treatments for bone-loss diseases such as osteoporosis. Every 30 seconds a person suffers an osteoporosis-related hip fracture in the EU.

24 Jul 2013

Ligand, Azure Biotech sign global license agreement for development of lasofoxifene

Ligand Pharmaceuticals Incorporated announces the signing of a global license agreement with Azure Biotech for the development of a novel formulation of lasofoxifene targeting an underserved market in women's health.

22 Jul 2013

Vitamin D-deficient older individuals are more likely to struggle with everyday tasks

Chevy Chase, MD-Vitamin D-deficient older individuals are more likely to struggle with everyday tasks such as dressing or climbing stairs, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

18 Jul 2013

Health benefits of short-chain fructooliogosaccharides

A new presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Expo in Chicago- focused on the health benefits of short-chain fructooliogosaccharides (scFOS), which are low-calorie, non-digestible carbohydrates that can improve food taste and texture while aiding immunity, bone health and the growth and balance of important bacteria in the digestive track.

17 Jul 2013

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

Qualigen, Inc., a privately owned company that provides rapid, easy to use, fully quantitative diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration for its FastPack Vitamin D Immunoassay for use on its proprietary FastPack System for the rapid determination of vitamin D status.

16 Jul 2013

Excess fat in liver, muscle tissue and blood may increase risk of bone loss

Excess fat around the belly has recently been identified as a risk factor for bone loss. Now, a new study has determined that excess liver and muscle fat also may be detrimental to bone.

16 Jul 2013

Osteoporosis News and Research

Latest Osteoporosis News and Research

Adheris files suit against HHS for attempting to restrain speech that serves public health interest

Osteoporosis drug could provide effective pain relief to patients with osteoarthritis

New systematic review analyzes patterns of vitamin D status worldwide

Southampton researchers investigates influence of mechanical forces on cellular, molecular processes

Researchers develop first animal model simulating eye complications linked with Graves' disease

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Coordinator-based FLS helps identify, manage people at high risk of secondary fractures

Researchers provide support for potential importance of vitamin D in pregnancy

FDA publishes new regulation defining "gluten-free" for food labeling to protect people with celiac disease

Reinnervate's Alvetex Scaffold system chosen for 3D osteocytic cell culture experiments in microgravity

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

FDA grants orphan-drug designation for Ligand’s Captisol-enabled Topiramate Injection

HONEI review shows that high glycemic index foods can exacerbate acne

Ligand Pharmaceuticals, Ethicor Pharma sign license agreement for lasofoxifene

UL researcher receives €1.5 million to develop innovative treatments for bone-loss diseases

Ligand, Azure Biotech sign global license agreement for development of lasofoxifene

Vitamin D-deficient older individuals are more likely to struggle with everyday tasks

Health benefits of short-chain fructooliogosaccharides

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

Excess fat in liver, muscle tissue and blood may increase risk of bone loss

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Osteoporosis News and Research

Latest Osteoporosis News and Research

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in